| Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial (NCT00578617) | Mayo Clinic | 2006-09-01 |
| KONVERT-AF - Relevance of Point in Time for Conversion of Acute Atrial Fibrillation (NCT00369330) | Atrial Fibrillation Network | 2006-09-01 |
| Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm (NCT00511173) | Creighton University | 2006-08-01 |
| Atrial Fibrillation Ablation Pilot Study (NCT00744835) | Medtronic Cardiac Rhythm and Heart Failure | 2006-08-01 |
| STAR-AF:Substrate Versus Trigger Ablation for Reduction of Atrial Fibrillation Trial (NCT00367757) | Abbott Medical Devices | 2006-08-01 |
| First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment (The RAAFT Study) (NCT00392054) | Population Health Research Institute | 2006-08-01 |
| The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With Enoxaparin (NCT00354796) | Hadassah Medical Organization | 2006-07-01 |
| Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients (NCT00814177) | Hamilton Health Sciences Corporation | 2006-07-01 |
| Effectiveness of Pulmonary Vein Isolation in Prevention of Atrial Fibrillation Following Heart Bypass Surgery (NCT00338715) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2006-07-01 |
| Efficacy and Safety Study of an Antiarrhythmic Drug to Treat Atrial Fibrillation in Patients With Pacemakers (NCT00389792) | ARYx Therapeutics | 2006-07-01 |
| Electrophysiological Effects of Irbesartan in Patients With Paroxysmal Atrial Fibrillation (AF) (NCT00352560) | Bristol-Myers Squibb | 2006-07-01 |
| BAY59-7939 in Atrial Fibrillation Once Daily (OD) (NCT00973245) | Bayer | 2006-07-01 |
| Lifetime Risk for Cardiovascular Disease Among Non-White Ethnic Groups (NCT00377702) | National Heart, Lung, and Blood Institute (NHLBI) | 2006-07-01 |
| Treatment of Atrial Fibrillation by Minimal Invasive Surgery (NCT00448656) | University Medical Center Groningen | 2006-06-01 |
| Resync-AF (Rate vs Rhythm Control in AF Patients With CRT-D) (NCT01233648) | University of Pittsburgh | 2006-06-01 |
| Atrial Fibrillation (AF) Clinic to Improve the Treatment of Patients With Atrial Fibrillation. (NCT00753259) | Maastricht University Medical Center | 2006-06-01 |
| Concomitant Surgical Atrial Fibrillation Ablation in Double Valve Replacement (NCT03163836) | Guangzhou General Hospital of Guangzhou Military Command | 2006-04-01 |
| High Intensity Focused Ultrasound (HIFU) Ablation System Study (NCT00392106) | ProRhythm, Inc. | 2006-04-01 |
| Concentrations of Amiodarone in Fat Tissue During Chronic Treatment (NCT00313443) | Hopital Lariboisière | 2006-04-01 |
| RATe Control in Atrial Fibrillation (NCT00313157) | Asker & Baerum Hospital | 2006-04-01 |
| Paroxysmal Atrial Fibrillation: Role of Inflammation, Oxidative Stress Injury and Effect of Statins (NCT00321802) | University of Calgary | 2006-04-01 |
| MINERVA: MINimizE Right Ventricular Pacing to Prevent Atrial Fibrillation and Heart Failure (NCT00262119) | Medtronic Cardiac Rhythm and Heart Failure | 2006-02-01 |
| A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study" (NCT00334464) | Intermountain Health Care, Inc. | 2006-02-01 |
| Study of T3 on the Incidence of Atrial Fibrillation in Patients Undergoing Cardiac Surgery (NCT00289367) | Northwell Health | 2006-02-01 |
| Prospective Registry of Pacemaker Patients Concerning Percentage of Right Ventricular Pacing, LVEF and NYHA Class (NCT00292539) | Guidant Corporation | 2006-02-01 |
| Randomized Trial of Two Different Strategies to Treat Paroxysmal Atrial Fibrillation (NCT00293943) | Atrial Fibrillation Network | 2006-02-01 |
| Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis (NCT00294775) | Odense University Hospital | 2006-02-01 |
| Study of Amiodarone Given Before Lung Surgery to Prevent Atrial Fibrillation After Lung Resection (NCT00300495) | Beth Israel Deaconess Medical Center | 2006-02-01 |
| n-3 Polyunsaturated Fatty Acids (PUFAs) in the Prevention of Atrial Fibrillation (NCT01198275) | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 2006-01-01 |
| Emulation of the Moderate Alcohol and Cardiovascular Health Trial (MACH15) (NCT06583161) | Harvard School of Public Health (HSPH) | 2006-01-01 |
| Efficacy and Safety of Electrical Versus Pharmacological Cardioversion in Early Atrial Fibrillation (NCT00933634) | Valduce Hospital | 2006-01-01 |
| Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers (NCT00225667) | Connolly, Stuart, M.D. | 2005-12-01 |
| Cardiac Surgical Treatment by Radiofrequency Ablation on Valvular Patients: Efficacy at 3 Months (NCT00259623) | University Hospital, Toulouse | 2005-12-01 |
| A Retrospective Analysis of the Use of ACE-inhibitors and Angiotensin Receptor Blockers (NCT00321945) | Emory University | 2005-12-01 |
| Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate (NCT00262600) | Boehringer Ingelheim | 2005-12-01 |
| A Retrospective Study of the Role of Thiazolidinediones to Reduce the Incidence of Atrial Arrhythmias (NCT00321204) | Emory University | 2005-12-01 |
| Study of RSD1235-SR for the Prevention of Atrial Fibrillation/Atrial Flutter Recurrence (NCT00267930) | Advanz Pharma | 2005-12-01 |
| Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke (NCT00240643) | GlaxoSmithKline | 2005-11-01 |
| Routine Mini-invasive Electrophysiology Study for Patients Feeling Tachycardia, With a Negative Holter ECG (NCT00251121) | Sykehuset Telemark | 2005-11-01 |
| A Dose Response Study of Dabigatran Etexilate(BIBR 1048) in Pharmacodynamics and Safety in Patients With Non-valvular Atrial Fibrillation in Comparison to Warfarin (NCT01136408) | Boehringer Ingelheim | 2005-11-01 |
| Electrophysiologically Guided PAcing Site Selection Study (NCT00239226) | Medtronic BRC | 2005-11-01 |
| Secondary Prevention of Atrial Fibrillation (Impact of Renin-Angiotensin-Aldosterone System Inhibition) (NCT01233635) | University of Pittsburgh | 2005-11-01 |
| After Discharge Management of Low Income Frail Elderly (NCT00328848) | Summa Health System | 2005-10-01 |
| Sole-Therapy Treatment of Atrial Fibrillation (NCT00566176) | AtriCure, Inc. | 2005-10-01 |
| Double Blind Placebo COntrolled Dose Ranging studY of the eFficacy and safEty of SSR149744c 300 or 600 mg for the Conversion of Atrial Fibrillation / fluttEr (NCT00232310) | Sanofi | 2005-10-01 |
| Atorvastatin Therapy for the Prevention of Atrial Fibrillation (SToP-AF) (NCT00252967) | Emory University | 2005-10-01 |
| First Arrhythmia Collection of Transvenous and Simultaneous Subcutaneous Implantable Defibrillator Data (NCT01161589) | Boston Scientific Corporation | 2005-10-01 |
| Study of RSD1235 to Evaluate Safety in Patients With Atrial Fibrillation (NCT00281554) | Astellas Pharma Inc | 2005-10-01 |
| FLAT Study: First Line Ablation Therapy for Treatment of Paroxysmal Atrial Fibrillation (RAAFT) (NCT00137540) | Biosense Webster EMEA | 2005-09-01 |
| Radiofrequency Ablation (RFA) Versus Antiarrhythmic Drug Treatment in Paroxysmal Atrial Fibrillation (NCT00133211) | Danish Heart Foundation | 2005-09-01 |
| BAY59-7939 Japanese in Atrial Fibrillation (2nd) (NCT00973323) | Bayer | 2005-09-01 |
| Efficacy and Safety of AZD7009 in the Treatment of Atrial Fibrillation (NCT00255281) | AstraZeneca | 2005-09-01 |
| Transesophageal Echocardiography to Identify pAtients With Low Risk of Stroke in Atrial Fibrillation - TIARA Pilot Study (NCT00224757) | The Interuniversity Cardiology Institute of the Netherlands | 2005-09-01 |
| Clinical and Economic Consequences of Left Atrial Bipolar Radiofrequency Ablation of Persistent and Permanent Atrial Fibrillation During Cardiac Surgery (NCT00157807) | Medtronic Cardiac Surgery | 2005-09-01 |
| Prevention of Atrial Fibrillation Following Esophagectomy (NCT00420017) | Indiana University | 2005-09-01 |
| Identification of Genetic, Biochemical and Hormonal Factors Contributing to Atrial Fibrillation (NCT00599118) | The Cleveland Clinic | 2005-08-01 |
| RF Ablation of Atrial Fibrillation (NCT00265629) | C. R. Bard | 2005-08-01 |
| Cardioversion vs. Catheter Ablation for Persistent Atrial Fibrillation (NCT00196209) | Deutsches Herzzentrum Muenchen | 2005-08-01 |
| Effects of Left Atrial Appendage Occlusion (NCT00510900) | University of Pittsburgh | 2005-08-01 |
| Treatment of Subclinical Hyperthyroidism (NCT00213720) | University Hospital, Strasbourg, France | 2005-08-01 |
| Markers of Oxidative Stress Present in Blood in Patients With Atrial Fibrillation (NCT00142194) | Emory University | 2005-06-01 |
| A Prospective Multi Centre Trial on Bipolar Radiofrequency Ablation of Atrial Fibrillation (NCT00184249) | Norwegian University of Science and Technology | 2005-06-01 |
| A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation (NCT00174785) | Sanofi | 2005-06-01 |
| Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation (NCT00111488) | Boston Scientific Corporation | 2005-06-01 |
| APAF: Assessment of Cardiac Resynchronization Therapy in Patients With Permanent Atrial Fibrillation (NCT00111527) | Azienda USL Reggio Emilia - IRCCS | 2005-05-01 |
| Markers of Oxidative Stress Present in Left Atrial Appendage Tissue in Patients With Atrial Fibrillation (NCT00243802) | Emory University | 2005-05-01 |
| SAFE Study - Septal Pacing for Atrial Fibrillation Suppression Evaluation (NCT00419640) | Abbott Medical Devices | 2005-05-01 |
| Silent Cerebrovascular Lesion and Cognitive Decline Prevention by Cholesterol Lowering in Elderly AF Patients (NCT00449410) | Radboud University Medical Center | 2005-05-01 |
| Atrial Fibrillation Rate Control Therapy Guided By Continuous Ambulatory Monitoring (NCT00115843) | Beth Israel Deaconess Medical Center | 2005-04-01 |
| Medical Economical Evaluation of the Ablation by Catheter of the Atrial Tissue in the Treatment of AF (NCT01183091) | Assistance Publique - Hôpitaux de Paris | 2005-04-01 |
| Renin-angiotensin-aldosterone System (RAAS), Inflammation, and Post-Operative Atrial Fibrillation (AF) (NCT00141778) | Vanderbilt University | 2005-04-01 |
| Catheter Ablation Versus Medical Treatment of AF in Heart Failure (NCT01411371) | Barts & The London NHS Trust | 2005-03-01 |
| Intra-Cardiac Echocardiography Guided Cardioversion(ICE-CHIP) Study (NCT00281073) | EP MedSystems | 2005-03-01 |
| Flecainide-Short Long Study (Flec-SL) (NCT00215774) | Atrial Fibrillation Network | 2005-03-01 |
| WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation (NCT00129545) | Boston Scientific Corporation | 2005-02-01 |
| Biochemical Marker to Predict the Recurrence of Atrial Fibrillation After Surgical Maze Procedure (NCT00542659) | Samsung Medical Center | 2005-02-01 |
| A Case Control Study to Investigate the Possible Association Between Atrial Fibrillation and Endothelium Dysfunction by Using Flow-Mediated Vasodilation Method (NCT00173966) | National Taiwan University Hospital | 2005-01-01 |
| Carvedilol Versus Metoprolol for the Prevention of Atrial Fibrillation After Off-Pump Coronary Bypass Surgery (NCT00198614) | Ministry of Health, Labour and Welfare, Japan | 2005-01-01 |
| A Trial of Circumferential Pulmonary Vein Ablation (CPVA) Versus Antiarrhythmic Drug Therapy in for Paroxysmal Atrial Fibrillation (AF) (NCT00340314) | IRCCS San Raffaele | 2005-01-01 |
| Recurrence of Atrial Fibrillation in Patients With Dual-chamber Pacemakers and Drug Therapy (NCT00215761) | Atrial Fibrillation Network | 2005-01-01 |
| Concomitant Treatment of Permanent Atrial Fibrillation (NCT00566787) | AtriCure, Inc. | 2005-01-01 |
| Omega 3 Fatty Acids and Atrial Fibrillation (NCT00508248) | University of Dundee | 2005-01-01 |
| The Genetic Basis of Atrial Fibrillation (AF) (NCT00248326) | University of Pittsburgh | 2005-01-01 |
| Atrial Tissue Banking: Atrial Tissue Obtained From Patients Undergoing Heart Surgery (NCT00248274) | University of Pittsburgh | 2005-01-01 |
| Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial Fibrillation (NCT00098137) | Atrial Fibrillation Network | 2005-01-01 |
| Biatrial Contractility Recovery After Maze (NCT02303652) | Centro Cardiologico Monzino | 2005-01-01 |
| Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects (NCT00126022) | Solvay Pharmaceuticals | 2004-12-01 |
| Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter (NCT00233441) | Sanofi | 2004-12-01 |
| Investigational Device Exemption (IDE) Study for the Approval of Closed Loop Stimulation (CLS) and Cardiac Resyncronization Pacing Therapies (CRT) for the Treatment of Atrial Fibrillation (AF) With Ablate and Pace (NCT00356057) | Biotronik, Inc. | 2004-12-01 |
| CACAF2 Study: Catheter Ablation for Cure of Atrial Fibrillation (NCT00227344) | Biosense Webster EMEA | 2004-12-01 |
| Cavotricuspid Isthmusblock and Circumferential Pulmonary Vein Isolation in Patients With Atrial Fibrillation (NCT00247780) | University of Aarhus | 2004-11-01 |
| Safety and Efficacy of CryoCor™ Cryoablation for PAF (NCT00231296) | Boston Scientific Corporation | 2004-11-01 |
| GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence (NCT00376272) | Gruppo di Ricerca GISSI | 2004-11-01 |
| The Use of DIOVAN to Reduce Post-Cardioversion Recurrence of Atrial Fibrillation Trial (the DRAFT Trial) (NCT00343499) | Intermountain Health Care, Inc. | 2004-11-01 |
| Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male Subjects (NCT00126061) | Solvay Pharmaceuticals | 2004-10-01 |
| NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation (NCT00116428) | Biosense Webster, Inc. | 2004-10-01 |
| Inflammation as a Predictor in Cardioversion of Atrial Fibrillation (NCT00590525) | Creighton University | 2004-10-01 |
| Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects (NCT00126074) | Solvay Pharmaceuticals | 2004-10-01 |
| Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial (NCT00256152) | Abbott Medical Devices | 2004-09-01 |
| Prevention of Atrial Fibrillation Following Noncardiac Thoracic Surgery (NCT00127712) | Indiana University | 2004-09-01 |